Remove 2018 Remove BioTech Remove Medicare Remove Patient Experience
article thumbnail

The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 2 of 5 – Amazon and One Medical

Health Populi

Iora Health has focused on the Medicare-enrolled population, distinct from ONEM’s target patient market of younger, employed consumers. With PillPack, I wrote here in June 2018 that Amazon got 50 U.S. The deal was announced on 21 July, with Amazon striking the price at about $3.9 bn and MGM Studios for $8.5

article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective. As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America.

BioTech 160